CIK 0001563880
- Non-accelerated filer
- Smaller reporting company
Trevi Therapeutics, Inc.
Sign in to watch- Ticker
- TRVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450834299
- Phone
- +1 203-304-2499
- Business address
- 195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $595,806
- in 1 filing, $596K under 10b5-1 plans
Net −$595,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 6 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-18 | New Enterprise Associates 16, L.P. 10% owner | Purchase | +1,851,852 | 7,789,850 | ||
| 2021-10-18 | New Enterprise Associates 16, L.P. 10% owner | Purchase · 3.5-Year Common Stock Warrant | +1,851,852 | 1,851,852 | ||
| 2021-10-18 | New Enterprise Associates 16, L.P. 10% owner | Purchase · 7-Year Common Stock Warrant | +1,851,852 | 1,851,852 | ||
| 2021-08-09 | Delfini Lisa Chief Financial Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2021-06-16 | Mathers Edward T Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-06-16 | VANLENT ANNE Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-06-16 | Cassella James V Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-06-16 | Heffernan Michael Thomas Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-06-16 | Colangelo Dominick Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-06-16 | Meeker David P Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-04-13 | Galletta Christopher | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-02-17 | GOOD JENNIFER L President & CEO | Grant or award · Stock Option (right to buy) | +160,000 | 160,000 | ||
| 2021-02-17 | Muscolo Frank P Controller | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-02-17 | Seiter Christopher Chief Financial Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2021-02-17 | SCIASCIA THOMAS Chief Medical Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-02-01 | Forbes William P Chief Development Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2020-06-29 | Colangelo Dominick Director | Grant or award · Nonstatutory Stock Option (right to buy) | +23,684 | 23,684 | ||
| 2020-06-11 | Mathers Edward T Director | Grant or award · Nonstatutory Stock Option (right to buy) | +14,210 | 14,210 | ||
| 2020-06-11 | VANLENT ANNE Director | Grant or award · Nonstatutory Stock Option (right to buy) | +14,210 | 14,210 | ||
| 2020-06-11 | Heffernan Michael Thomas Director | Grant or award · Nonstatutory Stock Option (right to buy) | +14,210 | 14,210 |
Page 13 of 21 · 419 trades